BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6702558)

  • 1. Efficacy of amiodarone during long-term treatment of potentially dangerous ventricular arrhythmias in patients with chronic stable ischemic heart disease.
    Kaski JC; Girotti LA; Elizari MV; Lázzari JO; Goldbarg A; Tambussi A; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):648-55. PubMed ID: 6702558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis.
    Chiale PA; Halpern MS; Nau GJ; Tambussi AM; Przybylski J; Lázzari JO; Elizari MV; Rosenbaum MB
    Am Heart J; 1984 Apr; 107(4):656-65. PubMed ID: 6702559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Anti-arrhythmic efficacy of the amiodarone-mexiletine combination in the treatment of resistant complex ventricular arrhythmias].
    Purcaro A; Massacci C; Curzi G; Pigini G; Costantini C; Bilancini A; Blandini A
    G Ital Cardiol; 1986 May; 16(5):417-26. PubMed ID: 3732727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiodarone in refractory life-threatening ventricular arrhythmias.
    Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
    Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy, safety and survival of patients with potentially lethal ventricular arrhythmias treated with low-dose amiodarone.
    Kerin NZ; Rubenfire M; Blevins RD; Frumin H; Faitel K; Jarandilla R; Aragon E; Marinescu G; Luarca R
    Clin Cardiol; 1988 Mar; 11(3 Suppl 2):II31-40. PubMed ID: 3271193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone.
    Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME
    Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long term follow-up.
    Peter T; Hamer A; Mandel WJ
    Eur Heart J; 1985 Nov; 6 Suppl D():151-62. PubMed ID: 4085515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 10. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
    Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
    Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
    Flaker GC; Alpert MA; Webel RR; Ruder MA; Sanfelippo JF; Tsutakawa RK
    Am Heart J; 1985 Aug; 110(2):371-6. PubMed ID: 4025112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amiodarone treatment in patients with ventricular arrhythmias.
    Prystowsky EN; Heger JJ; Miles WM; Zipes DP
    Drugs; 1985 Mar; 29 Suppl 3():47-52. PubMed ID: 3996245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amiodarone: an effective alternative for recalcitrant supraventricular and ventricular tachycardias.
    Best JF; Rinkenberger R; Lynch L; Dunn M
    Clin Cardiol; 1986 Jun; 9(6):268-71. PubMed ID: 2424656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation.
    Heger JJ; Prystowsky EN; Zipes DP
    Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ten years of experience with amiodarone.
    Rosenbaum MB; Chiale PA; Haedo A; Lázzari JO; Elizari MV
    Am Heart J; 1983 Oct; 106(4 Pt 2):957-64. PubMed ID: 6613843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous and oral loading versus oral loading alone with amiodarone for chronic refractory ventricular arrhythmias.
    Kerin NZ; Blevins RD; Frumin H; Faitel K; Rubenfire M
    Am J Cardiol; 1985 Jan; 55(1):89-91. PubMed ID: 3966403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of low doses of amiodarone on cardiac arrhythmias in patients with chronic ischaemic heart disease.
    Novo S; Alaimo G; Abrignani MG; Immordino R; Cutietta A; Indovina A; Licata G; Strano A
    Eur Heart J; 1988 Dec; 9 Suppl N():164-8. PubMed ID: 3246249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amiodarone in the treatment of patients with refractory symptomatic ventricular and supraventricular arrhythmias. A long-term follow-up study.
    Lloyd EA; Mabin TA
    S Afr Med J; 1983 May; 63(20):759-63. PubMed ID: 6342169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of amiodarone therapy in the treatment of drug-resistant cardiac arrhythmias: long-term follow-up.
    Peter T; Hamer A; Mandel WJ; Weiss D
    Am Heart J; 1983 Oct; 106(4 Pt 2):943-50. PubMed ID: 6613841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias.
    Haffajee CI; Love JC; Canada AT; Lesko LJ; Asdourian G; Alpert JS
    Circulation; 1983 Jun; 67(6):1347-55. PubMed ID: 6851030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.